On Nov 8, 2021 Beacon Biosignals closed a Series A round and raised $27,000,000 from Andrew Beck, Casdin Capital, General Catalyst, featuring lead investors General Catalyst.

About the company: Beacon Biosignals is located at United States, North America.
“AI + EEG to change the way patients are treated for disorders of the brain.”

Company website: http://www.beacon.bio